StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly cost of sales ($M) ($M)

Quarterly figures from Eli Lilly's filings and investor materials

QuarterlyAnnual
Latest, Q2 2026
3,268
Period ended Jun 30, 2026
Change on a year earlier
+33.5%
2,448 in Q2 2025
History
69 quarters
Since Q2 2008
Sources
57
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCost of sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20263,268+33.5%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20263,577+60.8%Form 10-Q (filed 2026-04-30) ↗
Q4 2025Dec 31, 20253,372+40.3%Form 10-K (filed 2026-02-12) ↗
Q3 2025Sep 30, 20253,008+38.6%Form 10-Q (filed 2025-10-30) ↗
Q2 2025Jun 30, 20252,448+12.8%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 20252,225+33.0%Form 10-Q (filed 2026-04-30) ↗
Q4 2024Dec 31, 20242,404+34.4%Form 10-K (filed 2026-02-12) ↗
Q3 2024Sep 30, 20242,171+16.7%Form 10-Q (filed 2024-10-30) ↗
Q2 2024Jun 30, 20242,170+20.1%Form 10-Q (filed 2024-08-08) ↗
Q1 2024Mar 31, 20241,674+2.9%Form 10-Q (filed 2024-04-30) ↗
Q4 2023Dec 31, 20231,788+15.5%Form 10-K (filed 2026-02-12) ↗
Q3 2023Sep 30, 20231,860+17.8%Form 10-Q (filed 2023-11-02) ↗
Q2 2023Jun 30, 20231,807+26.3%Form 10-Q (filed 2023-08-08) ↗
Q1 2023Mar 31, 20231,627-21.5%Form 10-Q (filed 2023-04-27) ↗
Q4 2022Dec 31, 20221,548-24.5%Form 10-K (filed 2023-02-22) ↗
Q3 2022Sep 30, 20221,579+10.4%Form 10-Q (filed 2022-11-01) ↗

Cite this data

StockData. (2026). Eli Lilly Cost of sales ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_cogs

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.